Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Mes

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
British Journal of Cancer|April 1, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancerM Koti, A Siu, I Clément, et al.
Lab on a Chip|December 15, 2015
Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapyM Astolfi, B Péant, M A Lateef, et al.
In Vitro Cellular & Developmental Biology. Animal|August 19, 2000
Characterization of four novel epithelial ovarian cancer cell linesD M Provencher, H Lounis, L Champoux, et al.
The French Journal of Urology|October 20, 2023
Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 dataC Dariane, F Chierigo, V Ouellet, et al.
Oncogene|January 31, 2017
The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancerY He, J J Northey, A Pelletier, et al.
American Journal of Human Genetics|October 30, 1998
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer familiesP N Tonin, A M Mes-Masson, P A Futreal, et al.
Oncogene|September 12, 2017
Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal traffickingD P Corkery, L E Clarke, S Gebremeskel, et al.
Oncogene|August 16, 2006
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3pN A L Cody, V Ouellet, E N Manderson, et al.
Human Heredity|August 22, 2001
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer familiesA P Manning, D Abelovich, P Ghadirian, et al.
Clinical Genetics|October 17, 2014
Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian populationE Castellsagué, J Liu, A Volenik, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
British Journal of Cancer|April 1, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancerM Koti, A Siu, I Clément, et al.
Lab on a Chip|December 15, 2015
Micro-dissected tumor tissues on chip: an ex vivo method for drug testing and personalized therapyM Astolfi, B Péant, M A Lateef, et al.
In Vitro Cellular & Developmental Biology. Animal|August 19, 2000
Characterization of four novel epithelial ovarian cancer cell linesD M Provencher, H Lounis, L Champoux, et al.
The French Journal of Urology|October 20, 2023
Analysis of active surveillance uptake for localized prostate cancer in Quebec in 2016: A Canadian bicentric study and comparison with 2010 dataC Dariane, F Chierigo, V Ouellet, et al.
Oncogene|January 31, 2017
The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancerY He, J J Northey, A Pelletier, et al.
American Journal of Human Genetics|October 30, 1998
Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer familiesP N Tonin, A M Mes-Masson, P A Futreal, et al.
Oncogene|September 12, 2017
Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal traffickingD P Corkery, L E Clarke, S Gebremeskel, et al.
Oncogene|August 16, 2006
Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3pN A L Cody, V Ouellet, E N Manderson, et al.
Human Heredity|August 22, 2001
Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer familiesA P Manning, D Abelovich, P Ghadirian, et al.
Clinical Genetics|October 17, 2014
Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian populationE Castellsagué, J Liu, A Volenik, et al.
Pageof 6